Effect of Exenatide on Brain, Adipose Tissue, Pancreas, and Liver Function

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Amylin Pharmaceuticals, LLC.

Information provided by (Responsible Party):

Ralph DeFronzo, MD, The University of Texas Health Science Center at San Antonio

ClinicalTrials.gov Identifier:

NCT01588418

First received: March 19, 2012

Last updated: December 1, 2014

Last verified: December 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2015
Estimated Primary Completion Date:	July 2015 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):